Skip to main content

Table 1 Correlations between HKDC1 expression and clinicopathologic features

From: HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK/mTOR signaling pathway

Characteristic HKDC1 expression p value
Low expression (%) High expression (%)
Age 0.681
 > 55 16 (30.77%) 36 (69.23%)  
 ≤ 55 6 (26.09%) 17 (73.91%)  
Sex 0.302
 Male 10 (24.39%) 31 (75.61%)  
 Female 12 (35.29%) 22 (64.71%)  
Tumor location 0.428
 Left lung 9 (25.00%) 27 (75.00%)  
 Right lung 13 (33.33%) 26 (66.67%)  
Histologic differentiation 0.003
 Well + moderate 20 (40.82%) 29 (59.18%)  
 Poor 2 (7.69%) 24 (92.31%)  
Pathological T stage 0.627
 T1–2 15 (31.25%) 33 (68.75%)  
 T3–4 7 (25.93%) 20 (74.07%)  
Pathological N stage 0.009
 N0 16 (43.24%) 21 (56.76%)  
 N+ 6 (15.79%) 32 (84.21%)  
TNM stage 0.843
 I + II 13 (30.23%) 30 (69.77%)  
 III + IV 9 (28.13%) 23 (71.87%)